by subject – Page 296 – Retraction Watch

“False data” forces retraction of Carbon paper co-authored by postdoc who led to PI’s suspension

There’s a new retraction in the journal Carbon.

The case didn’t involve a Carbon copy — say, plagiarism or duplication — but rather an instance of fraud in a Japanese university, part of a larger case we covered last August.

Here’s the retraction notice for the paper, “The role of Fe species in the pyrolysis of Fe phthalocyanine and phenolic resin for preparation of carbon-based cathode catalysts,” which appeared in August 2010: Continue reading “False data” forces retraction of Carbon paper co-authored by postdoc who led to PI’s suspension

Author retracts FASEB Journal paper for data reuse

The FASEB Journal has retracted a 2012 paper by a group from the University of Alabama, Birmingham (UAB), looking at the role of a tumor-suppressing micro-RNA in pulmonary fibrosis. The retraction suggests the provenance of the data are in question, and we learned details of what went wrong.

Here’s the notice, which, sadly, is behind a $12-per-day paywall: Continue reading Author retracts FASEB Journal paper for data reuse

First author of recently retracted paper has another corrected, in J Ag Food Chem

A paper that shares a first author with a paper retracted in December has been corrected.

Late last year, we reported on a retraction in Antioxidants & Redox Signaling (ARDS) by Indika Edirisinghe, who was at the University of Rochester when the original paper was published, and colleagues. On January 17, the Journal of Agricultural and Food Chemistry published a correction to “Effect of Black Currant Anthocyanins on the Activation of Endothelial Nitric Oxide Synthase (eNOS) in Vitro in Human Endothelial Cells,” on which Edirisinghe is also first author.

His affiliation on that paper, originally published in July 2011, is the Illinois Institute of Technology. Here’s the correction: Continue reading First author of recently retracted paper has another corrected, in J Ag Food Chem

Study of blood pressure drug valsartan retracted

Hiroaki Matsubara, a prominent cardiologist with five Expressions of Concern and two retractions for his CV, has another retraction.

As Larry Husten, who first reported the retraction at Forbes, notes, the notice for 2009’s “Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study,” which appeared in the European Heart Journal, says very little: Continue reading Study of blood pressure drug valsartan retracted

ORI says Case Western skin scientist falsified data

The U.S. Office of Research Integrity has sanctioned Bryan William Doreian, a former postdoc in dermatology at Case Western Reserve University in Cleveland, for falsifying data in his dissertation and a 2009 paper in Molecular Biology of the Cell (for which it provided a cover image, at right).

ORI says Doreian’s bad NIH-funded data also appeared in a manuscript submitted to, but never published in, Nature Medicine.

Here are the papers cited in the finding: Continue reading ORI says Case Western skin scientist falsified data

“Unreliable” findings fell TB gene study in PLOS ONE

Here’s a nice example of how science should work.

A team of Swiss microbiologists has retracted their 2012 paper in PLoS One on the genetics of the TB mycobacterium after learning that the fusion protein they thought they’d used in their study was in fact a different molecule.

Here’s the retraction notice for the article, “A β-lactamase based reporter system for ESX dependent protein translocation in mycobacteria,” which has been cited once, according to Thomson Scientific’s Web of Knowledge: Continue reading “Unreliable” findings fell TB gene study in PLOS ONE

Study finds many authors aren’t sharing data when they publish — and leads to a PLOS ONE retraction

A new study in Clinical Chemistry paints an alarming picture of how often scientists deposit data that they’re supposed to — but perhaps not surprisingly, papers whose authors did submit such data scored higher on a quality scale than those whose authors didn’t deposit their data.

Ken Witwer, a pathobiologist at Hopkins, was concerned that a lot of studies involving microarray-based microRNA (miRNA) weren’t complying with Minimum Information About a Microarray Experiment (MIAME) standards supposedly required by journals. So he looked at 127 such papers published between July 2011 and April 2012 in journals including PLOS ONE, the Journal of Biological Chemistry, Blood, and Clinical Chemistry, assigning each one a quality score and checking whether the authors had followed guidelines.

What he uncovered wasn’t pretty — and has already led to a retraction. From the abstract: Continue reading Study finds many authors aren’t sharing data when they publish — and leads to a PLOS ONE retraction

Salami slicing in pork research leads to retractions

We get accused of grabbing at cheap puns around here, but the headline above is meant to be taken straight up.

Three journals in the food sciences are retracting a trio of papers published last year on bacterial contamination in pork products because the articles used the same data sets — a classic (Platonic?) case of “salami slicing.”

The Journal of Food Protection, which published one of the articles, “Performance of three culture media commonly used for detecting Listeria monocytogenes,” has the following retraction notice:

Continue reading Salami slicing in pork research leads to retractions

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: